Dr. Irfan Vaziri

Claim this profile

Nebraska Hematology - Oncology, P.C.

Studies Plasma Cell Neoplasm
Studies Multiple Myeloma
1 reported clinical trial
4 drugs studied

Affiliated Hospitals

Image of trial facility.
Nebraska Hematology-Oncology, PC

Clinical Trials Irfan Vaziri is currently running

Image of trial facility.

SPd vs EloPd Chemotherapy

for Multiple Myeloma

This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of SPd versus EloPd in pomalidomide-naïve patients with MM who have received 1 to 4 prior anti-MM regimens and been treated with an immunomodulatory imide drug (IMiD), proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody (mAb).
Recruiting2 awards Phase 318 criteria

More about Irfan Vaziri

Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Irfan Vaziri has experience with
  • Dexamethasone Oral
  • Elotuzumab
  • Pomalidomide
  • Selinexor
Breakdown of trials Irfan Vaziri has run
Plasma Cell Neoplasm
Multiple Myeloma

Other Doctors you might be interested in

Kailash MosalpuriaNebraska Hematology-Oncology, P.C.

Frequently asked questions

Do I need insurance to participate in a trial?
What does Irfan Vaziri specialize in?
Is Irfan Vaziri currently recruiting for clinical trials?
Are there any treatments that Irfan Vaziri has studied deeply?
What is the best way to schedule an appointment with Irfan Vaziri?
What is the office address of Irfan Vaziri?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security